Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.

Oelmann E, Kraemer A, Serve H, Reufi B, Oberberg D, Patt S, Herbst H, Stein H, Thiel E, Berdel WE.

Int J Cancer. 1997 Jun 11;71(6):1066-76.

2.

The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.

Roots-Weiss A, Papadimitriou C, Serve H, Hoppe B, Koenigsmann M, Reufi B, Oberberg D, Thiel E, Berdel WE.

Bone Marrow Transplant. 1997 Jun;19(12):1239-46.

3.

Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34(+) hematopoietic cells.

Papadimitriou C, Roots A, Koenigsmann M, Oelmann E, Topp M, Oberberg D, Reufi B, Thiel E, Berdel W.

Int J Oncol. 1996 Dec;9(6):1107-12.

PMID:
21541618
5.

Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy.

Koenigsmann MP, Notter M, Knauf WU, Papadimitriou CA, Oberberg D, Reufi B, Mücke C, Thiel E, Berdel WE.

Bone Marrow Transplant. 1996 Sep;18(3):549-57.

PMID:
8879616
6.

Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.

Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi B, Mücke C, Minty A, Thiel E, Berdel WE.

Cancer Res. 1996 Aug 1;56(15):3583-8.

7.

Generation of progenitor-cell precursors in long-term bone-marrow cultures after marrow purging with ether lipids.

Zimmer B, Reufi B, Oberberg D, Thiel E, Berdel W.

Int J Oncol. 1995 Dec;7(6):1307-13.

PMID:
21552965
8.

Immunomagnetic selection of CD34+ cells from fresh peripheral blood mononuclear cell preparations using two different separation techniques.

Papadimitriou CA, Roots A, Koenigsmann M, Koenigsmann M, Mücke C, Oelmann E, Oberberg D, Reufi B, Thiel E, Berdel WE.

J Hematother. 1995 Dec;4(6):539-44.

PMID:
8846014
9.

Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines.

Papadimitriou CA, Topp MS, Serve H, Oelmann E, Koenigsmann M, Maurer J, Oberberg D, Reufi B, Thiel E, Berdel WE.

Eur J Cancer. 1995 Dec;31A(13-14):2371-8.

PMID:
8652271
10.

Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism.

Topp MS, Papadimitriou CA, Eitelbach F, Oelmann E, Koehler B, Oberberg D, Von Marschall Z, Reufi B, Stein H, Thiel E, et al.

Leuk Lymphoma. 1995 Oct;19(3-4):319-28.

PMID:
8535226
11.

Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies.

Topp MS, Papadimitriou CA, Eitelbach F, Koenigsmann M, Oelmann E, Koehler B, Oberberg D, Reufi B, Stein H, Thiel E, et al.

Cancer Res. 1995 May 15;55(10):2173-6.

12.

Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.

Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.

Cancer Res. 1995 May 15;55(10):2212-9.

13.

Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitro.

Oelmann E, Topp M, Reufi B, Papadimitriou C, Koenigsmann M, Oberberg D, Thiel E, Berdel W.

Int J Oncol. 1994 Mar;4(3):555-8.

PMID:
21566958
14.

Macrophage inflammatory protein (mip)-1-alpha stem-cell inhibitor (sci) does not affect clonal growth of human solid tumor-cell lines in-vitro.

Korfel A, Vonmarschall Z, Koenigsmann M, Oberberg D, Reufi B, Thiel E, Berdel W.

Int J Oncol. 1994 Feb;4(2):353-7.

PMID:
21566931
15.

Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo.

Topp MS, Koenigsmann M, Mire-Sluis A, Oberberg D, Eitelbach F, von Marschall Z, Notter M, Reufi B, Stein H, Thiel E, et al.

Blood. 1993 Nov 1;82(9):2837-44.

16.

Urokinase-type plasminogen-activator (upa), a protease with cytokine-like activity in human hl-60 leukemic-cell line.

Berdel W, Wilhelm O, Schmitt M, Maurer J, Reufi B, Vonmarschall Z, Oberberg D, Graeff H, Thiel E.

Int J Oncol. 1993 Oct;3(4):607-13.

PMID:
21573407
17.

Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivo.

Topp M, Koenigsmann M, Miresluis A, Oberberg D, Eitelbach F, Vonmarschall Z, Notter M, Reufi B, Stein H, Thiel E, Berdel W.

Int J Oncol. 1993 Aug;3(2):167-70.

PMID:
21573343
18.

Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene.

Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J, Ludwig WD, Kreuser ED, Thiel E, et al.

Cancer Res. 1992 Jun 15;52(12):3498-502.

19.

Effects of hematopoietic growth factors on malignant nonhematopoietic cells.

Berdel WE, Danhauser-Riedl S, Oberberg D, Zafferani M.

Semin Oncol. 1992 Apr;19(2 Suppl 4):41-5.

PMID:
1553574
20.
21.

Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines.

Serve H, Steinhauser G, Oberberg D, Flegel WA, Northoff H, Berdel WE.

Cancer Res. 1991 Aug 1;51(15):3862-6.

22.
23.

Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.

Danhauser-Riedl S, Felix SB, Houlihan WJ, Zafferani M, Steinhauser G, Oberberg D, Kalvelage H, Busch R, Rastetter J, Berdel WE.

Cancer Res. 1991 Jan 1;51(1):43-8.

Supplemental Content

Loading ...
Support Center